Boosting the in-vitro effectiveness of photodynamic therapy on MCF-7 breast cancer cells with encapsulated malachite green by silica nanoparticles

Photodynamic therapy (PDT) is a promising cancer treatment strategy utilizing photosensitizers (PS) and light to generate singlet oxygen, with Malachite Green (MG) showing high singlet oxygen quantum yield. Effective delivery of MG to the target tissue remains a key challenge. Encapsulation techniques have been investigated to improve PS delivery, minimize PS leakage, inhibit diaphorase-induced reduction, and mitigate PS-related toxicity. Silica nanoparticles (SiNPs) offer favorable characteristics for drug delivery in PDT and serve as promising delivery carriers. In this study, SiNPs were synthesized and employed as carriers for MG. The size and shape of nanoparticles were determined using Transmission Electron Microscopy (TEM). A range of concentrations of MG were applied to MCF-7 breast cancer cells in order to evaluate the cytotoxicity of both naked and encapsulated MG. This helped identify the most effective concentrations and exposure durations required to induce damage under red laser light (Intensity ∼110 mW/cm²). The results indicated that SiNPs-encapsulated MG exhibited superior efficacy compared to naked MG, with a concentration efficacy increase of +50 % and an exposure time efficacy increase of +45 %. This underlines the enhanced capability of encapsulated MG to eliminate MCF-7 cells when compared to naked MG. The application of synthesized SiNPs for MG delivery improved the effectiveness of photodynamic therapy by augmenting MG bioavailability in target cells.